Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Pleural Mesothelioma, Advanced”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00006014
What this trial is testing

SU5416 in Treating Patients With Malignant Mesothelioma

Who this might be right for
Malignant Mesothelioma
National Cancer Institute (NCI) 45
Large-scale testing (Phase 3)Not Yet RecruitingNCT07824986
What this trial is testing

Trial in Advanced Epithelioid Mesothelioma

Who this might be right for
Pleural MesotheliomaMesothelioma
Vivace Therapeutics, Inc 350
Testing effectiveness (Phase 2)UnknownNCT00030459
What this trial is testing

Palliative Therapy With or Without Chemotherapy in Treating Patients With Malignant Mesothelioma

Who this might be right for
Malignant Mesothelioma
British Thoracic Society
Early research (Phase 1)Study completedNCT04153565
What this trial is testing

Pembrolizumab in Combination With Cisplatin and Pemetrexed in Advanced Malignant Pleural Mesothelioma (MPM) (MK-3475-A17)

Who this might be right for
Mesothelioma
Merck Sharp & Dohme LLC 19
Testing effectiveness (Phase 2)Study completedNCT00354393
What this trial is testing

Combination Chemotherapy With or Without Surgery & Chemoradiotherapy in Patients With Malignant Pleural Mesothelioma

Who this might be right for
Malignant Mesothelioma
The Cleveland Clinic 9
Testing effectiveness (Phase 2)Active Not RecruitingNCT03907852
What this trial is testing

Phase 1/2 Trial of Gavo-cel (TC-210) in Patients With Advanced Mesothelin-Expressing Cancer

Who this might be right for
MesotheliomaMesothelioma, MalignantMesothelioma; Pleura+8 more
TCR2 Therapeutics 57
Testing effectiveness (Phase 2)Study completedNCT00392444
What this trial is testing

Sunitinib in Treating Patients With Advanced Malignant Pleural Mesothelioma

Who this might be right for
Advanced Malignant MesotheliomaRecurrent Malignant Mesothelioma
National Cancer Institute (NCI) 39
Early research (Phase 1)Ended earlyNCT04166734
What this trial is testing

Pembrolizumab and Hypofractionated Stereotactic Radiotherapy in Patients With Malignant Pleural Mesothelioma

Who this might be right for
Advanced Malignant Pleural Mesothelioma
Royal Marsden NHS Foundation Trust 5
Early research (Phase 1)Study completedNCT02369198
What this trial is testing

MesomiR 1: A Phase I Study of TargomiRs as 2nd or 3rd Line Treatment for Patients With Recurrent MPM and NSCLC

Who this might be right for
Malignant Pleural MesotheliomaNon-Small Cell Lung Cancer
Asbestos Diseases Research Foundation 27
Testing effectiveness (Phase 2)Study completedNCT00309946
What this trial is testing

Cediranib Maleate in Treating Patients With Malignant Mesothelioma That Cannot Be Removed By Surgery

Who this might be right for
Advanced Malignant MesotheliomaEpithelial MesotheliomaLocalized Malignant Mesothelioma+2 more
National Cancer Institute (NCI) 51
Not applicableLooking for participantsNCT07126509
What this trial is testing

Partial Pleurectomy (Surgery) for Unresectable Pleural Mesothelioma

Who this might be right for
MesotheliomaMesothelioma; LungMesotheliomas Pleural+2 more
University of Chicago 30
Testing effectiveness (Phase 2)UnknownNCT00002465
What this trial is testing

High-Dose Megestrol in Treating Patients With Metastatic Breast Cancer, Endometrial Cancer, or Mesothelioma

Who this might be right for
Breast CancerEndometrial CancerMalignant Mesothelioma
St. Vincent Medical Center - Los Angeles
Testing effectiveness (Phase 2)Study completedNCT00004254
What this trial is testing

Raltitrexed in Treating Patients With Malignant Mesothelioma That Cannot Be Surgically Removed

Who this might be right for
Malignant Mesothelioma
European Organisation for Research and Treatment of Cancer - EORTC 25
Testing effectiveness (Phase 2)Study completedNCT00004183
What this trial is testing

Capecitabine in Treating Patients With Malignant Mesothelioma

Who this might be right for
Malignant Mesothelioma
Alliance for Clinical Trials in Oncology 27
Early research (Phase 1)Study completedNCT00019825
What this trial is testing

Decitabine in Treating Patients With Unresectable Lung or Esophageal Cancer or Malignant Mesothelioma of the Pleura

Who this might be right for
Esophageal CancerLung CancerMalignant Mesothelioma+1 more
National Cancer Institute (NCI)
Large-scale testing (Phase 3)Study completedNCT03762018
What this trial is testing

BEAT-meso: Bevacizumab and Atezolizumab in Malignant Pleural Mesothelioma

Who this might be right for
Pleural Mesothelioma Malignant Advanced
ETOP IBCSG Partners Foundation 400
Testing effectiveness (Phase 2)Ended earlyNCT05500508
What this trial is testing

Oral AMXT 1501 Dicaprate in Combination With IV DFMO

Who this might be right for
CancerSolid TumorSolid Carcinoma+17 more
Aminex Therapeutics, Inc. 15
Early research (Phase 1)Ended earlyNCT02029690
What this trial is testing

Ph 1 Study in Subjects With Tumors Requiring Arginine to Assess ADI-PEG 20 With Pemetrexed and Cisplatin

Who this might be right for
Pleural Mesothelioma Malignant AdvancedPeritoneal Mesothelioma Malignant AdvancedNon-squamous Non-small Cell Lung Carcinoma+4 more
Polaris Group 85
Early research (Phase 1)Study completedNCT00030498
What this trial is testing

Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction

Who this might be right for
Adult Anaplastic AstrocytomaAdult Anaplastic EpendymomaAdult Anaplastic Oligodendroglioma+83 more
National Cancer Institute (NCI) 75
Early research (Phase 1)Active Not RecruitingNCT04491942
What this trial is testing

Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer

Who this might be right for
Advanced Bile Duct CarcinomaAdvanced Breast CarcinomaAdvanced Cervical Carcinoma+31 more
National Cancer Institute (NCI) 74
Next Page